Health outcomes following COVID-19 infection and vaccination in hereditary hemorrhagic telangiectasia
Abstract Background There has been concern that individuals living with Hereditary Hemorrhagic Telangiectasia (HHT) could be at higher risk for poor outcomes if infected with SARS-CoV2, the virus that causes COVID-19 disease. As literature is lacking on outcomes on COVID-19 infection and vaccination...
Saved in:
| Main Authors: | Christopher M. Tarulli, Xiayi Ma, Kamalprit Chokar, Nicholas T. Vozoris, Marianne S. Clancy, Marie E. Faughnan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-025-03561-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
by: John M. Lee, et al.
Published: (2019-10-01) -
Cobalamin and iron deficiency still presents a challenge in hereditary hemorrhagic telangiectasia
by: Marie Carolin Schleupner, et al.
Published: (2025-08-01) -
Quantifying the burden of hereditary hemorrhagic telangiectasia on quality of life and psychological health: a cross-sectional study
by: Anna J. Gong, et al.
Published: (2025-03-01) -
Coexistence of Hereditary Hemorrhagic Telangiectasia and Moyamoya Disease: A Case Report Highlighting a Potential Genetic Synergy
by: Liu S, et al.
Published: (2025-07-01) -
Brain and lung arteriovenous malformation rescreening practices for children and adults with hereditary hemorrhagic telangiectasia
by: Lauren A. Beslow, et al.
Published: (2024-11-01)